Correlation Between Cingulate Warrants and Kiora Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Kiora Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Kiora Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Kiora Pharmaceuticals, you can compare the effects of market volatilities on Cingulate Warrants and Kiora Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Kiora Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Kiora Pharmaceuticals.
Diversification Opportunities for Cingulate Warrants and Kiora Pharmaceuticals
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cingulate and Kiora is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Kiora Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiora Pharmaceuticals and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Kiora Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiora Pharmaceuticals has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Kiora Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cingulate Warrants and Kiora Pharmaceuticals
Assuming the 90 days horizon Cingulate Warrants is expected to generate 1.29 times less return on investment than Kiora Pharmaceuticals. In addition to that, Cingulate Warrants is 4.08 times more volatile than Kiora Pharmaceuticals. It trades about 0.0 of its total potential returns per unit of risk. Kiora Pharmaceuticals is currently generating about 0.02 per unit of volatility. If you would invest 362.00 in Kiora Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of 2.00 from holding Kiora Pharmaceuticals or generate 0.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 98.44% |
| Values | Daily Returns |
Cingulate Warrants vs. Kiora Pharmaceuticals
Performance |
| Timeline |
| Cingulate Warrants |
| Kiora Pharmaceuticals |
Cingulate Warrants and Kiora Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate Warrants and Kiora Pharmaceuticals
The main advantage of trading using opposite Cingulate Warrants and Kiora Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Kiora Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiora Pharmaceuticals will offset losses from the drop in Kiora Pharmaceuticals' long position.| Cingulate Warrants vs. Puma Biotechnology | Cingulate Warrants vs. Iovance Biotherapeutics | Cingulate Warrants vs. Sarepta Therapeutics | Cingulate Warrants vs. Day One Biopharmaceuticals |
| Kiora Pharmaceuticals vs. Virax Biolabs Group | Kiora Pharmaceuticals vs. Revelation Biosciences | Kiora Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Kiora Pharmaceuticals vs. Allarity Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |